|
SUNDAY,
SEPTEMBER 29, 2002 |
MONDAY,
SEPTEMBER 30, 2002 |
TUESDAY,
OCTOBER 1, 2002 |
WEDNESDAY,
OCTOBER 2, 2002 |
THURSDAY,
OCTOBER 3, 2002 |
| Orals |
Orals
|
Posters |
Orals
|
Posters |
Orals
|
Posters
|
Orals
|
Posters
|
| THURSDAY, OCTOBER 3,
2002 |
| POSTER SESSION:
THERAPIES IN APS |
| 1 |
LONG
TERM ANTICOAGULANT THERAPY IN PATIENTS WITH APS: OUR EXPERIENCE
O. Illera-Martin, J. Cesar, A. Garcia-Abello, A. Zea,
Spain |
| 2 |
FRAXIPARIN
USING IN PREGNANT WOMEN HAVING APS
V.K .Chaica, T.N. Demina, S. Dghelomanova, Ukraine |
| 3 |
PLASMAPHERESIS
USING IN COMPLEX TREATMENT OF PREGNANT WOMEN HAVING APS
T.N. Demina, E.B. Yakovleva, S.V. Cheremnych, Ukraine |
| 4 |
CONVENTIONAL
ORAL ANTICOAGULATION (INR 2-3) EFFECTIVELY PREVENTS RE-THROMBOSIS
IN PRIMARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME
P.R.J. Ames, A. Ciampa, E. Grandone, M. Margaglione,
G. Scenna, L. Iannaccone,
V. Brancaccio, Italy |
| 5 |
INDUCTION
OF ORAL TOLERANCE IN EXPERIMENTAL APS BY FEEDING WITH POLYCLONAL
IMMUNOGLOBULINS
I. Krause, M. Blank, Y. Sherer, B. Gilburd, F. Kvapil,
Y. Shoenfeld, Israel |
| 6 |
DOWNREGULATION
OF EXPERIMENTAL SLE AND APS BY TNF-ALPHA DNA VACCINATION
M. Blank, I. Krause, G. Wildbaum, N. Karin, Y. Shoenfeld,
Israel |
| 7 |
EFFICACY
OF AFFINITY PURIFIED ANTI-dsDNA
ANTI-IDIOTYPIC ANTIBODIES IN THE TREATMENT OF EXPERIMENTAL
SLE
Y. Shoenfeld, L. Rauova, B. Gilbure, L. Ziporen, F.
Kvapil, I. Goldberg, J. Kopolovic,
J. Rovensky, M. Blanc, Israel, Slovakia |
| 8 |
ANTIPHOSPHOLIPID
ANTIBODIES (APA) IN PATIENTS WITH LES: PREVENTION OF THROMBOSIS
P. Mesiano, L. Colla, L. Besso, F. Bermond, A. Messuerotti,
C. Marcuccio, C. Canavese, P. Stratta, Italy |
| 9 |
TREATMENT
APS NEPHROPATHY (APSN) PATIENTS IN PRIMARY APS
N.L. Kozlovskaya, E.A. Shachnova, N.A. Meteleva, V.V.
Kushnir,
E.M. Shilov, Russia
|
|
|
| POSTER SESSION:
APOPTOSIS, ANTIBODIES AND APS |
| 10 |
aPLS-
CLINICAL CORRELATION AND STATISTICS OF THE DEPARTMENT (1984-2002)
C.M.C.A. Tonel, J M Matoso Fereira, T. Pereira, L.
Araujo, J. Lourenco, C. Pina,
A. Ribeiro, M. Alves, F. Esteves, L. Morais, M. Noronha, Portugal |
| 11 |
CLINICAL
AND RESEARCH DATABASE FOR SLE AND APS WITH SAPPORO AND ACR
CRITERIA LINKED TO POINT-OF SERVICE ENTRY
G.A. McCarty, T.E. Cason, J. Meade, M. Zang, USA |
| 12 |
APOPTOSIS
OF T CELLS IN WOMEN WITH A HISTORY OF THROMBOPHILIA AND RECURRENT
SPONTANEOUS ABORTION
M.M. Jerzak, M. Kasprzycka, M. Semczuk, A. Gorski,
Poland |
| 13 |
THE
EFFECT OF SERA FROM WOMEN WITH SLE OR APS AND RECURRENT ABORTIONS
ON HUMAN PLACENTAL EXPLANTS IN CULTURE
A. Ornoy, S. Yacobi, Z. Blumenfeld, R. K. Miller, Israel,
USA |
| 14 |
ANTI-B2GPI
ANTIBODIES AS THE SOLE ANTIBODIES: ABOUT 11 PATIENTS
C. Desauw, E. Hachulla, M. Lambert, S. Dubucquoi, U.
Pasturel, A.L. Fauchais,
V. Queyrel, P.Y. Hatron, B. Devulder, France |
| |
| POSTER SESSION:
DIAGNOSTICS KITS |
| 15 |
CONFIRMATORY
dRVVT ON MIX SAMPLES IMPROVED SENSITIVITY AND SPECIFICITY
FOR LUPUS ANTICOAGULANT (LA) IN PATIENTS UNDER ORAL ANTICOAGULATION
(OA)
A.N. Blanco, L.P. Gennari, S.H. Grosso, P. Cassais,
M.A. Lazzari, Argentina |
| 16 |
A
SIMPLE RELATIONSHIP BETWEEN TWO APTT REAGENTS AS A CONFIRMATORY
TEST IN THE DIAGNOSIS OF LUPUS ANTICOAGULANT (LA) IN ORAL
ANTICOAGULATED (OA) PATIENTS
L.C. Gennari, A.N. Blanco, S.H. Grosso, P. Cassais,
M.A. Lazzari, Argentina |
| 17 |
METHODOLOGICAL
DIFFERENCE BETWEEN DIFFERENT ANTICARDIOLIPIN ELISAS: THE USE
OF PURIFIED BOVINE B2GPI
C. Biasini Rebaioli, M. Frassi, M. Spunghi, B. Abissoni,
E. Ervas, F. Allegri, A. Tincani, G. Balestrieri, Italy |
| 18 |
OMEGA-CARBOXYL
VARIANTS OF 7-KETOCHOLESTERYL ESTERS ARE LIGANDS FOR B2GPI
K. Kobayashi, Q. Liu, T. Yasuda, D.R. Voelker, T. Koike,
E. Matsuura, Japan, USA |
| 19 |
IMMUNOLOGIC
EVALUATION IN WOMEN WITH SPONTANEOUS ABORTIONS
G. Kortebani, L. Rodriguez Rilo, A.B. Mazzolli, Argentina |
| 20 |
CLINICAL
SIGNIFICANCE OF aCL AND A-B2GPI ANTIBODIES
G. Obermoser, W. Bitterlich, F. Kunz, N. Sepp, Austria |
| 21 |
CONCENTRATION
OF PHOSPHOLIPID IN DRVVT REAGENTS MAY AFFECT THE DIAGNOSIS
OF LUPUS ANTICOAGULANT (LA)
I. Jennings, S. Kitchen, T.A.L. Woods, I. Cartwright,
F.E. Preston, UK |
| 22 |
USE
OF MONOCLONAL ANTIBODIES AS STANDARD MATERIAL FOR A-B2GPI,
aPT AND aPL IMMUNOASSAYS
K. Rodolfo, A. Guilloteau, S. Le Floch, V. Quignon,
M. Grimaux, B.J. Woodhams, France |
| 23 |
STUDY
OF ASSOCIATION BETWEEN CLINICAL MANIFESTATIONS AND aPLS IN
A COHORT OF PATIENTS WITH THE APS
M.A. Aguirre, R. Roldan, A. Escudero, M. Romero, P.
Font, E. Collantes, Spain |
| 24 |
PREVALENCE
OF IGG ANTI-PHOSPHATIDYLETHANOLAMINE (Ape) ANTIBODIES IN SLE
J. Kuca, L. Olsen, K. Dier, C. Fink, D. Wagenknecht,
J. McIntyre, L. Lopez, USA |
| 25 |
COMPARISON
OF THREE ELISA METHODS FOR THE DETECTION OF ANTI-B2GPI ANTIBODIES
K. Dier, T. Buckner, L. Olsen, C. Fink, L. Lopez, USA |
| 26 |
IONIC
STRENGTH EFFECTS ON TESTS FOR LUPUS ANTICOAGULANT
T. Exner, J. Low, J. Joseph, Australia |
| 27 |
A
NOVEL FLOWCYTOMETIC METHOD TO DETECT
AUTO-ANTIBODIES RELATED TO PREGNANCY LOST
S. Shai, G. Fihman, R. Shabo, Y. Shoenfeld, Israel |
| 28 |
THE
ANTI-PHOSPHOLIPID/COFACTOR SYNDROME:
THE RESULT OF ROUTINE SCREENING FOR ANTIBODIES TO B2GPI UPON
SUSPICION OF THE APS
J. Damoiseaux, M. Wijffels, L. Van Pampus, J.W. Cohen-Tervaert,
P. Van Paesen,
The Netherlands |
| |
| POSTER SESSION:
TREATMENT |
| 29 |
DRUG
ABUSE INITIATES SLE IN A PATIENT WITH PRIMARY APS
G. Pohla-Gubo, M. Wieser, Austria |
| |
| POSTER SESSION:
ANTI-PROTHROMBIN |
| 30 |
OPTIMIZATION
OF PHOSPHATIDYLSERINE DEPENDENT ANTI-PROTHROMBIN ELISA
A. Ambrozic, T. Kveder, P. Zigon, B. Bozic, Slovenia |
| 31 |
aPL,
ANTIPROTEIN ANTIBODIES AND HOMOCYSTEINE AS RISK FACTORS FOR
A FIRST PREGNANCY LOSS BETWEEN 8 AND 10 WEEKS OF PREGNANCY:
A MATCHED CASE-CONTROL STUDY
J.-C. Gris, E. Mercier, I. Quere, H. Dechaud, M. Hoffet,
S. Rippart-Neveu, P. Mares,
T.V. Perneger, France, Switzerland |
| 32 |
MONOCLONAL
ANTIBODIES AGAINST THE COMPLEX OF PHOSPHATIDYLSERINE AND PROTHROMBIN
FROM PATIENTS WITH THE APS
K. Ichikawa, T. Horita, T. Atsumi, S. Jodo, Y. Amasaki,
T. Koike, Japan |
| 33 |
RELEVANCE
OF ANTI PROTHROMBIN ANTIBODIES IN PATEINTS WITH VENOUS AND/OR
ARTERIAL THROMBOSIS
B. Montaruli, A. Vaccarino, C. Foli, S. Plateroti,
M. Saitta, L. Cavagna, M. Bazzan, Italy |
| |
| POSTER SESSION:
CYTOKINES AND HORMONES |
| 34 |
CORRELATION
BETWEEN LEVEL OF ESTROGEN AND aPLS SUBCLASSES IN SLE
D. Martinovic, M. Radic, L. Giunio, D. Fabijanic, Croatia |
| 35 |
APS
IN MALE LUPUS
N.G. Kljukvina, S.V. Shekshina, A.A. Baranov, E.L.
Nassonov, Russia |
| 36 |
CYTOKINES
AND THE APS
M. Ehrenfeld, H. Amital, Y. Shoenfeld, Israel |
| 37 |
CYTOKINE
GENE POLYMORPHISM IN APS
C.G. Echenique, M.B. Rodriguez Cardozo, J.U. Scher,
G.R. Bierfass,
D.S. Fernandez Romero, J.O. Latino, M. Pesaresi, A.M. Di Lonardo,
Argentina |
| |
| POSTER SESSION:
OBSTETRIC THERAPY |
| 38 |
UNFRACTIONATED
VERSUS LOW-MOLECULAR-WEIGHT HEPARIN IN TREATMENT OF APS DURING
PREGNANCY
A. Ruffatti, M. Ermani, M. Favaro, A. Calligaro, C.
Radu, M. Tonello, P. Grypiotis,
T. Del Ross, S. Todesco, Italy |
| 39 |
DOES
THE MATERNAL DOSE RESPONSE TO LOW MOLECULAR WEIGHT HEPARIN
VARY DURING PREGNANCY? A LONGITUDINAL PROSPECTIVE STUDY
V.C. Sephton, R. Farquharson, J. Topping, C. Cowan,
S. Quenby, D. Back, C. Toh, UK |
| 40 |
PROSPECTIVE
OBSERVATIONAL STUDY OF BONE MINERAL DENSITY DURING PREGNANCY:
LOW MOLECULAR WEIGHT HEPARIN VS CONTROL
A.J. Carlin, R.G. Farquharson, S.M. Quenby, J. Topping,
W. Fraser, UK |
| 41 |
EVOLUTION
AND RESPONSE TO TREATMENT IN PATIENTS WITH POSITIVE ANTICARDIOLIPIN
ANTIBODIES
J.J. Alegre-Sancho, C. Fern?ndez-Carballido, J.A. Rom?n-Ivorra,
O. Viana, P. Molina, M.J. Ripoll, I. Mart?nez, S. Fern?ndez,
Spain |
| |
| POSTER SESSION:
T CELL AND APS |
| 42 |
RESTRICTED
T CELL RECEPTOR BETA-CHAIN USAGE BY T CELLS AUTOREACTIVE TO
BETA2-GLYCOPROTEIN I IN PATIENTS WITH APS
M. Kuwana, K. Yoshida, T. Arai, J. Kaburaki, Y. Kawakami,
Y. Ikeda, Japan |
| 43 |
LOCALIZATION
OF T CELL EPITOPES ON PROTHROMBIN IN PATIENTS POSITIVE FOR
aPT
T. Sumida, K. Yoshida, Y. Ohnishi, A. Tsutsumi, Japan |
| 44 |
FUNCTIONAL
CHARACTERIZATION OF CD8+ T SUPPRESSOR CELLS
G. Filaci, M. Fravega, S. Negrini, D. Fenoglio, M.
Basso, F. Indiveri, Italy |
| POSTER SESSION:
CANCER |
| 45 |
FREQUENCY
OF MALIGNANT TUMOURS IN A SERIES OF 238 PATIENTS WITH SLE
AND APS
M. Mora, J. I. Bernardino, L. Diez, A. Robles, P. Lavilla,
N. Sastre, A. Gil Aguado, Spain |
| |
| POSTER SESSION:
DIAGNOSTICS, SCREENING, PROGNOSIS AND OTHER DISEASES |
| 46 |
TESTING
FOR ANTIBODIES AGAINST OTHER PHOSPHOLIPIDS THAN CARDIOLIPIN
IMPROVES THE DIAGNOSTIC OF THE APS
R. Woehrle, M. Oppermann, T. Matthias, K. Helmke, Germany |
| 47 |
LONGITUDINAL
ANALYSIS OF MARKERS OF IMPAIRED TROPHOBLAST INVASION AND MATERNAL
ENDOTHELIAL DYSFUNCTION IN APS PREGNANCIES
S. Stone, B.J. Hunt, P.T. Seed, K. Parmer, K. Langford,
M.A. Khamashta, L. Poston, UK |
SUNDAY,
SEPTEMBER 29, 2002 |
MONDAY,
SEPTEMBER 30, 2002 |
TUESDAY,
OCTOBER 1, 2002 |
WEDNESDAY,
OCTOBER 2, 2002 |
THURSDAY,
OCTOBER 3, 2002 |
| Orals |
Orals
|
Posters |
Orals
|
Posters |
Orals
|
Posters
|
Orals
|
Posters
|
|
|
